Use of changes in B-type natriuretic peptides to detect ischemia in selected patients

被引:7
|
作者
Staub, Daniel [1 ,2 ]
Jauslin, Daniel [1 ]
Freidank, Heike [3 ]
Taegtmeyer, Anne [1 ]
Breidthardt, Tobias [1 ]
Zellweger, Michael J. [1 ]
Mueller-Brand, Jan [4 ]
Christ, Michael [1 ]
Mueller, Christian [1 ]
机构
[1] Univ Hosp, Dept Internal Med, CH-4031 Basel, Switzerland
[2] Rush Univ, Med Ctr, Cardiol Sect, Dept Internal Med, Chicago, IL 60612 USA
[3] Univ Basel Hosp, Dept Lab Med, Basel, Switzerland
[4] Univ Basel Hosp, Dept Nucl Med, Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Natriuretic peptides; Ischemia; Exercise; ST-SEGMENT ELEVATION; EMISSION COMPUTED-TOMOGRAPHY; INDUCED MYOCARDIAL-ISCHEMIA; CORONARY-ARTERY-DISEASE; HEART-FAILURE; PROGNOSTIC VALUE; ANGINA-PECTORIS; ACUTE DYSPNEA; CHEST-PAIN; EXERCISE;
D O I
10.1016/j.ijcard.2008.04.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is accumulating evidence that transient exercise-induced ischemia triggers the release of B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). The aim of this study was to either confirm or refute a previous investigation suggesting that myocardial ischemia can reliably be detected by exercise-induced changes in BNP or NT-proBNP levels in selected patients. Methods: A total of 139 consecutive patients with normal left ventricular function and normal resting BNP and NT-proBNP levels referred for rest/stress myocardial perfusion single-photon emission computed tomography (SPECT) were analyzed. Levels of BNP and NT-proBNP were determined before and immediately after symptom-limited bicycle ergometry. Results: Inducible myocardial ischemia on perfusion images was detected in 46 patients (33%). Median exercise-induced increases in BNP (Delta BNP) and NT-proBNP (Delta NT-proBNP) were similar in patients with and without inducible ischemia (Delta BNP 12.7 pg/ml vs. 9.4 pg/ml, p = 0.109; Delta NT-proBNP 7 pg/ml vs. 6 pg/ml, p = 0.309). The area under the receiver operating characteristic curve for the ability to detect myocardial ischemia was 0.583 (95% CI, 0.479-0.688) for Delta BNP, and 0.553 (95% CI, 0.450-0.656) for Delta NT-proBNP. Conclusions: Exercise-induced changes in BNP and NT-proBNP do not reliably detect myocardial ischemia in selected patients. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 50 条
  • [41] Changes in B-type natriuretic peptide levels do not detect differences in volume removed by ultrafiltration or diuretics in patients with heart failure
    Guglin, Maya E.
    Feller, Erika D.
    Costanzo, Maria Rosa
    Anderson, Allen S.
    Sobotka, Paul A.
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S116 - S116
  • [42] The use of B-type natriuretic peptide in the management of patients with diabetes and acute dyspnoea
    Mueller, C
    Laule-Kilian, K
    Christ, A
    Perruchoud, AP
    DIABETOLOGIA, 2006, 49 (04) : 629 - 636
  • [43] Use of glitazones in cardiac patients: A case for B-type natriuretic peptide monitoring?
    El Muayed, ML
    Lavis, VR
    Safi, HJ
    Fuentes, F
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (05): : 600 - 602
  • [44] The use of B-type natriuretic peptide to assess volume status in dialysis patients
    Codognotto, Marta
    Piccoli, Antonio
    AMERICAN HEART JOURNAL, 2007, 154 (05)
  • [45] The Jury Is Still Out on A-Type Natriuretic Peptide Deficiency Relative to B-Type Natriuretic Peptides
    Gandhi, Parul U.
    Herman, Paige E.
    Gaggin, Hanna K.
    JACC-HEART FAILURE, 2024, 12 (03) : 475 - 478
  • [46] State of the art of immunoassay methods for B-type natriuretic peptides: An update
    Clerico, Aldo
    Franzini, Maria
    Masotti, Silvia
    Prontera, Concetta
    Passino, Claudio
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2015, 52 (02) : 56 - 69
  • [47] The use of B-type natriuretic peptide in the management of patients with diabetes and acute dyspnoea
    C. Mueller
    K. Laule-Kilian
    A. Christ
    A. P. Perruchoud
    Diabetologia, 2006, 49 : 629 - 636
  • [48] The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea
    Breidthardt, Tobias
    Noveanu, Markus
    Cayir, Sevgi
    Viglino, Martina
    Laule, Kirsten
    Hochholzer, Willibald
    Reichlin, Tobias
    Potocki, Mihael
    Christ, Michael
    Mueller, Christian
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 136 (02) : 193 - 199
  • [49] The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea
    Bredthardt, Tobias
    Laule-Kilian, Kirsten
    Klima, Theresia
    Hochholzer, Willibald
    Perruchoud, Andre P.
    Christ, Michael
    Mueller, Christian
    CIRCULATION, 2006, 114 (18) : 408 - 408
  • [50] Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects
    Sun, LS
    Dominguez, C
    Mallavaram, NA
    Quaegebeur, JM
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (05): : 1104 - 1110